ALG1L7P

Across TCGA pan-cancer cohorts, ALG1L7P RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated ALG1L7P data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher ALG1L7P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated ALG1L7P expression acts as an unfavorable survival marker, although some lineages such as UVM and LGG show a favorable association.

LIHC, KIRC, and KICH are the cancer types where ALG1L7P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	DFS	Tertile	All	0.361	0.582	<.001	64	view →
KIRC	OS	Median	All	0.842	0.902	.004	62	view →
KICH	OS	Median	II,III,IV	0.571	1.000	.001	53	view →
UVM	OS	Tertile	All	0.878	0.483	<.001	48	view →
LUAD	DFS	Median	II,III,IV	0.615	0.812	.003	46	view →
LGG	OS	Median	All	0.880	0.738	<.001	43	view →
UCS	DFS	Median	IV	0.952	0.367	.001	36	view →
HNSC	DFS	Quartile	IV	0.426	0.255	.002	28	view →
SKCM	DFS	Quartile	II,III,IV	0.791	0.604	.005	14	view →
BLCA	DFS	Median	All	0.425	0.241	.019	13	view →
MESO	DFS	Median	All	0.297	0.424	.026	9	view →
DLBC	DFS	Median	II,III,IV	0.592	0.971	.023	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 23 lineages.

ALG1L7P–LIHC (DFS)

Open the LIHC breakdown →